InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: buckysherm post# 3434

Thursday, 08/30/2018 1:45:10 PM

Thursday, August 30, 2018 1:45:10 PM

Post# of 3834
Maybe or not

BMY has clearly shown interest in NASH- and they were testing GRMD02 with Yervoy. They can test with Opdivo as PD-1 to get similar results. So BMY could do full BO

MERCK will need it for Ketruda - however the drug is same for both indications - so it is a buy 1 get 1 free
They can buy the co and sell rights for NASH to GILD on revenue sharing basis and recover cost of BO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News